antibody drug conjugate insight: pipeline assessment, technology trend, and competitive landscape,...
TRANSCRIPT
www.MarketResearchReports.com
Antibody Drug Conjugate Insight:
Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015
Category : Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: March 1, 2015
Number of Pages: 342
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 3,500
Price For Site User License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015, report provides the information across the ADCs drug value chain.
The Report has covered the 264 Antibody-drug conjugates profile which gives core information of the targets, mechanism of action, development partner, Technology partner, monoclonal antibody used, linker used and cytotoxic drug with the descriptive information of the technologies.
The Report also provides the assessment of the company’s undergone collaborations for technology and monoclonal antibody and also gives insights over the pre-clinical and clinical data.
www.MarketResearchReports.com
Key Findings:
Antibody-Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds.
The ongoing research on this therapy will replace the chemotherapeutics treatments in the near future thereby reducing its toxic side effects.
Billions of dollars are spent on the chemotherapy treatments annually. Different Biotechnology companies and Pharma Companies are collaborating in all area of ADCs like linker technology, antibody production and conjugation process.
www.MarketResearchReports.com
Key Findings: Continues…
Pipeline is very rich with four potential drugs in Phase III stage out of which Kadcyla and Adcetris are undergoing clinical studies for different conditions.
According to Publisher Analysis, North America has the highest number of development in ADCs with 161 ADCs and 65 Active companies followed by Europe with 38 active companies and 81 products and Asia Pacific with 18 ADCs in development.
www.MarketResearchReports.com
Scope:
A snapshot of the global Antibody-Drug Conjugate market scenario, market trends & drivers, manacles of Antibody-Drug Conjugate.
A review of the marketed Antibody-Drug Conjugate products and marketing status
Coverage of global antibody-drug conjugate therapies under development across the globe covering territories
Competitive landscape of investigational products for key players and key therapy areas.
The Antibody-Drug Conjugate report covers the product description, stage of development, licensors & collaborators, Development partner and Technology information
www.MarketResearchReports.com
Scope: Continues…
The Report also provides the pre-clinical and clinical outcomes of the therapies
The Report has covered the targets and detailed mechanism of action
Report has highlighted the licensing opportunities and funding details for therapies
The report also gives the information of dormant and discontinued pipeline projects
www.MarketResearchReports.com
Reason to Buy:
Complete Market and Pipeline intelligence and complete understanding over therapeutics development for Antibody-Drug Conjugate
Devise corrective measures for pipeline projects by understanding Therapy area specific therapies
Developing strategic initiatives to support your Antibody-Drug Conjugate development activities.
Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
www.MarketResearchReports.com
Reason to Buy: Continues…
Evaluate the marketing and pipeline strategy for antibody-drug conjugate therapies and their funding details.
Identifying the upcoming leaders in the Antibody-Drug Conjugate market in the coming years.
www.MarketResearchReports.com
Report Coverage:
1. Introduction
2. Executive Summary
3. Scope of the Report
4. Antibody-Drug Conjugate Introduction
5. Companies in Collaboration for Technology
6. Global Sales Assessment of Adcetris
7. Report Methodology
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://mrr.cm/4fY
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)